- Report
- April 2024
- 180 Pages
Global
From €4012EUR$4,500USD£3,482GBP
- Report
- February 2024
- 182 Pages
Global
From €4012EUR$4,500USD£3,482GBP
- Report
- February 2024
- 170 Pages
Global
From €4012EUR$4,500USD£3,482GBP
- Report
- October 2023
- 88 Pages
Malaysia
From €3121EUR$3,500USD£2,708GBP
- Report
- October 2023
- 89 Pages
Malaysia
From €3121EUR$3,500USD£2,708GBP
- Report
- October 2023
- 83 Pages
Israel
From €3121EUR$3,500USD£2,708GBP
- Report
- August 2023
- 75 Pages
Canada
From €3121EUR$3,500USD£2,708GBP
- Report
- August 2023
- 74 Pages
United States
From €3121EUR$3,500USD£2,708GBP
- Report
- July 2024
- 152 Pages
Global
From €4235EUR$4,750USD£3,675GBP
- Report
- April 2023
- 111 Pages
Global
From €4235EUR$4,750USD£3,675GBP
- Report
- March 2024
- 200 Pages
Global
From €3700EUR$4,150USD£3,211GBP
- Report
- February 2024
- 131 Pages
Global
From €4235EUR$4,750USD£3,675GBP
- Report
- October 2022
- 110 Pages
Global
From €4235EUR$4,750USD£3,675GBP
- Report
- August 2022
- 117 Pages
Global
From €4235EUR$4,750USD£3,675GBP
From €3121EUR$3,500USD£2,708GBP
- Report
- November 2024
- 88 Pages
India
From €3121EUR$3,500USD£2,708GBP
- Report
- April 2024
- 183 Pages
Global
From €4012EUR$4,500USD£3,482GBP
- Report
- November 2023
- 182 Pages
Global
From €4012EUR$4,500USD£3,482GBP
- Report
- October 2023
- 90 Pages
India
From €3121EUR$3,500USD£2,708GBP
- Report
- October 2023
- 73 Pages
Malaysia
From €3121EUR$3,500USD£2,708GBP

Age-related Macular Degeneration (AMD) is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. It is the leading cause of vision loss in people over the age of 50. AMD is a major concern for the optical industry, as it can lead to severe vision impairment and blindness.
Optical companies are developing treatments and technologies to help diagnose and manage AMD. These include optical coherence tomography (OCT) imaging, which can detect early signs of AMD, and anti-VEGF drugs, which can slow the progression of the disease. Additionally, companies are developing new lenses and other optical devices to help improve vision in those with AMD.
Companies in the AMD market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more